CarboneC., PiroG., TamburrinoA., MinaM. M., ZaniniS., TortoraG. and MelisiD. (2013) “TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance”, JOP. Journal of the Pancreas, 14(5S), p. 562. doi: 10.6092/1590-8577/1866.